acer therapeutics is a biotech company, headquartered in cambridge, ma, that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs. acer's lead candidate, edviso™ (celiprolol), is the

ACER THERAPEUTICS INC

Sold all ACER

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Sold 67% of ACER

Sold 48% of ACER

Gregg

Bought 50% more ACER

New position in ACER

Sold <1% of ACER

Sold 55% of ACER

Sold 27% of ACER

Bought 100% more ACER

Sold 40% of ACER

Abdel Al

Stanley Soman

Bought 9% more ACER

Andrew Cameron

Sold 20% of ACER